Democratic nominee for president former Secretary of State Hillary Clinton.
Melina Mara | The Washington Post | Getty Images
If biotech stocks continue to fall, it means we will likely have a President Hillary Clinton. The sector's shares are perfectly inversely correlated to her chances of winning the presidency, according to Strategas Research Partners.
Clinton presidential probability vs. biotech/S&P 500
Source: Strategas Research Partners
In addition to the presidential election, Strategas says the other critical events for the drug and biotech industry include the results of the November California drug price control referendum and who wins the House of Representatives.
